NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/26/2024
Back to search
Official data from USPTO
AXIS PHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
11/26/2024
Trademark type
Combined
Nice classes
1, 42
Filing date
10/18/2023
Registration date
11/26/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2024
Last transaction
11/26/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/28/2018
First use in commerce
04/28/2018
Drawing code
3
Owner type
16
Owner location
San Diego, CA
Examiner
PENDLETON, CAROLYN
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of "AXIS PHARM" in all capital letters. "AXIS" is written almost double the size of "PHARM". The horizontal line of "A" continues outside the letter to the right, winging upwards. The backslash of the "X" in "AXIS" contributes to an ovular loop tilted at around 45 degrees, and is meant to look like a ring encompassing the top of the slash in "X", "I", and part of "S". The ring does not go through "S" but is meant to appear to go behind it. "PHARM" is written tightly underneath "AX" and is consequently outside and to the left of the ring.
Holders and representatives
Holders
AxisPharm LLC
Representatives
Yan Gao Gao Law, P.C.
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents for research purposes; Reagents for scientific and research use; Reagents for use in scientific apparatus for chemical or biological analysis; Biochemical reagents commonly known as probesfor detecting and analyzing molecules in protein or nucleotide arrays; Biochemical reagents used for non-medical purposes; Biomedical compoundspeptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Chemical reagents for non-medical purposes; Chemical reagentsother than for medical or veterinary purpose; Fluorescent dye for scientific or research use
Class 42
Laboratory research services relating to pharmaceuticals; Scientific research; Scientific research and development; Scientific research consulting; Designengineeringresearchdevelopment and testing services in the field of polymeric materialspolymer synthesismaterials customization for medicalscientifictechnological applications; Providing reagent sample testing and diagnostic services for others for scientific research purposes
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/24/2024
PUBO
PUBLISHED FOR OPPOSITION
09/24/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/22/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/21/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/21/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/11/2024
GNRT
NON-FINAL ACTION E-MAILED
06/11/2024
CNRT
NON-FINAL ACTION WRITTEN
06/11/2024
DOCK
ASSIGNED TO EXAMINER
06/04/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/06/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/06/2024
NWAP
NEW APPLICATION ENTERED
10/18/2023
Continuous trademark protection
Get notified about every new filing that threatens AXIS PHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.